Jessica R. Walter, Comeron W. Ghobadi, Emily Hayman, Shuai Xu: Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance. Obstetrics and Gynecology, January 2017, nro 1, s. 10–19. PubMed:27926652doi:10.1097/AOG.0000000000001796ISSN 1873-233XArtikkelin verkkoversio.
Scott G. Chudnoff, John E. Nichols, Mark Levie: Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. Journal of Minimally Invasive Gynecology, September 2015, nro 6, s. 951–960. PubMed:25917278doi:10.1016/j.jmig.2015.04.017ISSN 1553-4669Artikkelin verkkoversio.
Mario Franchini, Brunella Zizolfi, Carmela Coppola, Valentino Bergamini, Cecilia Bonin, Giovanni Borsellino: Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey. Journal of Minimally Invasive Gynecology, May 2017, nro 4, s. 640–645. PubMed:28232037doi:10.1016/j.jmig.2017.02.004ISSN 1553-4669Artikkelin verkkoversio.
Huse Kamencic, Luke Thiel, Erwin Karreman, John Thiel: Does Essure Cause Significant De Novo Pain? A Retrospective Review of Indications for Second Surgeries After Essure Placement. Journal of Minimally Invasive Gynecology, November 2016, nro 7, s. 1158–1162. PubMed:27569594doi:10.1016/j.jmig.2016.08.823ISSN 1553-4669Artikkelin verkkoversio.
J. E. Arjona Berral, B. Rodríguez Jiménez, E. Velasco Sánchez, B. Povedano Cañizares, J. Monserrat Jordan, J. Lorente Gonzalez: Essure® and chronic pelvic pain: a population-based cohort. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, November 2014, nro 8, s. 712–713. PubMed:24910944doi:10.3109/01443615.2014.920795ISSN 1364-6893Artikkelin verkkoversio.
Zain A. Al-Safi, Valerie I. Shavell, Deslyn T. G. Hobson, Jay M. Berman, Michael P. Diamond: Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. Journal of Minimally Invasive Gynecology, November 2013, nro 6, s. 825–829. PubMed:24183273doi:10.1016/j.jmig.2013.05.006ISSN 1553-4669Artikkelin verkkoversio.
E. Jokinen, A. Heino, T. Karipohja, M. Gissler, R. Hurskainen: Safety and effectiveness of female tubal sterilisation by hysteroscopy, laparoscopy, or laparotomy: a register based study. BJOG: an international journal of obstetrics and gynaecology, 2.5.2017. PubMed:28464415doi:10.1111/1471-0528.14719ISSN 1471-0528Artikkelin verkkoversio.
nih.gov
pubmed.ncbi.nlm.nih.gov
Jessica R. Walter, Comeron W. Ghobadi, Emily Hayman, Shuai Xu: Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance. Obstetrics and Gynecology, January 2017, nro 1, s. 10–19. PubMed:27926652doi:10.1097/AOG.0000000000001796ISSN 1873-233XArtikkelin verkkoversio.
E. Scott Sills, Marie M. Dalton: Patient Outcomes Following Injury from Hysteroscopic Sterilization. Surgical Technology International, April 2016, nro 28, s. 165–169. PubMed:27042777ISSN 1090-3941Artikkelin verkkoversio.
Scott G. Chudnoff, John E. Nichols, Mark Levie: Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. Journal of Minimally Invasive Gynecology, September 2015, nro 6, s. 951–960. PubMed:25917278doi:10.1016/j.jmig.2015.04.017ISSN 1553-4669Artikkelin verkkoversio.
Mario Franchini, Brunella Zizolfi, Carmela Coppola, Valentino Bergamini, Cecilia Bonin, Giovanni Borsellino: Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey. Journal of Minimally Invasive Gynecology, May 2017, nro 4, s. 640–645. PubMed:28232037doi:10.1016/j.jmig.2017.02.004ISSN 1553-4669Artikkelin verkkoversio.
Huse Kamencic, Luke Thiel, Erwin Karreman, John Thiel: Does Essure Cause Significant De Novo Pain? A Retrospective Review of Indications for Second Surgeries After Essure Placement. Journal of Minimally Invasive Gynecology, November 2016, nro 7, s. 1158–1162. PubMed:27569594doi:10.1016/j.jmig.2016.08.823ISSN 1553-4669Artikkelin verkkoversio.
J. E. Arjona Berral, B. Rodríguez Jiménez, E. Velasco Sánchez, B. Povedano Cañizares, J. Monserrat Jordan, J. Lorente Gonzalez: Essure® and chronic pelvic pain: a population-based cohort. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, November 2014, nro 8, s. 712–713. PubMed:24910944doi:10.3109/01443615.2014.920795ISSN 1364-6893Artikkelin verkkoversio.
Zain A. Al-Safi, Valerie I. Shavell, Deslyn T. G. Hobson, Jay M. Berman, Michael P. Diamond: Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. Journal of Minimally Invasive Gynecology, November 2013, nro 6, s. 825–829. PubMed:24183273doi:10.1016/j.jmig.2013.05.006ISSN 1553-4669Artikkelin verkkoversio.
E. Jokinen, A. Heino, T. Karipohja, M. Gissler, R. Hurskainen: Safety and effectiveness of female tubal sterilisation by hysteroscopy, laparoscopy, or laparotomy: a register based study. BJOG: an international journal of obstetrics and gynaecology, 2.5.2017. PubMed:28464415doi:10.1111/1471-0528.14719ISSN 1471-0528Artikkelin verkkoversio.
ncbi.nlm.nih.gov
Jessica R. Walter, Comeron W. Ghobadi, Emily Hayman, Shuai Xu: Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance. Obstetrics and Gynecology, January 2017, nro 1, s. 10–19. PubMed:27926652doi:10.1097/AOG.0000000000001796ISSN 1873-233XArtikkelin verkkoversio.
E. Scott Sills, Marie M. Dalton: Patient Outcomes Following Injury from Hysteroscopic Sterilization. Surgical Technology International, April 2016, nro 28, s. 165–169. PubMed:27042777ISSN 1090-3941Artikkelin verkkoversio.
Scott G. Chudnoff, John E. Nichols, Mark Levie: Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. Journal of Minimally Invasive Gynecology, September 2015, nro 6, s. 951–960. PubMed:25917278doi:10.1016/j.jmig.2015.04.017ISSN 1553-4669Artikkelin verkkoversio.
Mario Franchini, Brunella Zizolfi, Carmela Coppola, Valentino Bergamini, Cecilia Bonin, Giovanni Borsellino: Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey. Journal of Minimally Invasive Gynecology, May 2017, nro 4, s. 640–645. PubMed:28232037doi:10.1016/j.jmig.2017.02.004ISSN 1553-4669Artikkelin verkkoversio.
Huse Kamencic, Luke Thiel, Erwin Karreman, John Thiel: Does Essure Cause Significant De Novo Pain? A Retrospective Review of Indications for Second Surgeries After Essure Placement. Journal of Minimally Invasive Gynecology, November 2016, nro 7, s. 1158–1162. PubMed:27569594doi:10.1016/j.jmig.2016.08.823ISSN 1553-4669Artikkelin verkkoversio.
J. E. Arjona Berral, B. Rodríguez Jiménez, E. Velasco Sánchez, B. Povedano Cañizares, J. Monserrat Jordan, J. Lorente Gonzalez: Essure® and chronic pelvic pain: a population-based cohort. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, November 2014, nro 8, s. 712–713. PubMed:24910944doi:10.3109/01443615.2014.920795ISSN 1364-6893Artikkelin verkkoversio.
Zain A. Al-Safi, Valerie I. Shavell, Deslyn T. G. Hobson, Jay M. Berman, Michael P. Diamond: Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. Journal of Minimally Invasive Gynecology, November 2013, nro 6, s. 825–829. PubMed:24183273doi:10.1016/j.jmig.2013.05.006ISSN 1553-4669Artikkelin verkkoversio.
E. Jokinen, A. Heino, T. Karipohja, M. Gissler, R. Hurskainen: Safety and effectiveness of female tubal sterilisation by hysteroscopy, laparoscopy, or laparotomy: a register based study. BJOG: an international journal of obstetrics and gynaecology, 2.5.2017. PubMed:28464415doi:10.1111/1471-0528.14719ISSN 1471-0528Artikkelin verkkoversio.
Jessica R. Walter, Comeron W. Ghobadi, Emily Hayman, Shuai Xu: Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance. Obstetrics and Gynecology, January 2017, nro 1, s. 10–19. PubMed:27926652doi:10.1097/AOG.0000000000001796ISSN 1873-233XArtikkelin verkkoversio.
E. Scott Sills, Marie M. Dalton: Patient Outcomes Following Injury from Hysteroscopic Sterilization. Surgical Technology International, April 2016, nro 28, s. 165–169. PubMed:27042777ISSN 1090-3941Artikkelin verkkoversio.
Scott G. Chudnoff, John E. Nichols, Mark Levie: Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. Journal of Minimally Invasive Gynecology, September 2015, nro 6, s. 951–960. PubMed:25917278doi:10.1016/j.jmig.2015.04.017ISSN 1553-4669Artikkelin verkkoversio.
Mario Franchini, Brunella Zizolfi, Carmela Coppola, Valentino Bergamini, Cecilia Bonin, Giovanni Borsellino: Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey. Journal of Minimally Invasive Gynecology, May 2017, nro 4, s. 640–645. PubMed:28232037doi:10.1016/j.jmig.2017.02.004ISSN 1553-4669Artikkelin verkkoversio.
Huse Kamencic, Luke Thiel, Erwin Karreman, John Thiel: Does Essure Cause Significant De Novo Pain? A Retrospective Review of Indications for Second Surgeries After Essure Placement. Journal of Minimally Invasive Gynecology, November 2016, nro 7, s. 1158–1162. PubMed:27569594doi:10.1016/j.jmig.2016.08.823ISSN 1553-4669Artikkelin verkkoversio.
J. E. Arjona Berral, B. Rodríguez Jiménez, E. Velasco Sánchez, B. Povedano Cañizares, J. Monserrat Jordan, J. Lorente Gonzalez: Essure® and chronic pelvic pain: a population-based cohort. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, November 2014, nro 8, s. 712–713. PubMed:24910944doi:10.3109/01443615.2014.920795ISSN 1364-6893Artikkelin verkkoversio.
Zain A. Al-Safi, Valerie I. Shavell, Deslyn T. G. Hobson, Jay M. Berman, Michael P. Diamond: Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. Journal of Minimally Invasive Gynecology, November 2013, nro 6, s. 825–829. PubMed:24183273doi:10.1016/j.jmig.2013.05.006ISSN 1553-4669Artikkelin verkkoversio.
E. Jokinen, A. Heino, T. Karipohja, M. Gissler, R. Hurskainen: Safety and effectiveness of female tubal sterilisation by hysteroscopy, laparoscopy, or laparotomy: a register based study. BJOG: an international journal of obstetrics and gynaecology, 2.5.2017. PubMed:28464415doi:10.1111/1471-0528.14719ISSN 1471-0528Artikkelin verkkoversio.